Kura Oncology (KURA) Misses Q1 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q1 EPS of ($0.59), $0.04 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• Carnival shares drop despite earnings beat on weak guidance